Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Endonovo Therapeutics, Inc. (ENDV)
:ENDV
Holding ENDV?
Track your performance easily
ENDV Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume29.52M
Average Volume (3M)18.90M
Market Cap
$127.50K
Enterprise Value$7.43M
Total Cash (Recent Filing)$55.53K
Total Debt (Recent Filing)$4.22K
Price to Earnings (P/E)―
Beta-0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding318,751,600
10 Day Avg. Volume31,873,690
30 Day Avg. Volume18,900,512
Standard Deviation0.39
R-Squared0.00517
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.20
Enterprise Value/Market Cap58.30
Enterprise Value/Revenue29.07
Enterprise Value/Gross Profit59.29
Enterprise Value/Ebitda-2.95
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
ENDV FAQ
What was Endonovo Therapeutics, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Endonovo Therapeutics, Inc.’s market cap?
Endonovo Therapeutics, Inc.’s market cap is $127.50K.
When is Endonovo Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Endonovo Therapeutics, Inc.’s earnings last quarter?
Endonovo Therapeutics, Inc. released its earnings results on Aug 19, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Endonovo Therapeutics, Inc. overvalued?
According to Wall Street analysts Endonovo Therapeutics, Inc.’s price is currently Overvalued.
Does Endonovo Therapeutics, Inc. pay dividends?
Endonovo Therapeutics, Inc. does not currently pay dividends.
What is Endonovo Therapeutics, Inc.’s EPS estimate?
Endonovo Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Endonovo Therapeutics, Inc. have?
Endonovo Therapeutics, Inc. has 318,751,600 shares outstanding.
What happened to Endonovo Therapeutics, Inc.’s price movement after its last earnings report?
Endonovo Therapeutics, Inc. reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Endonovo Therapeutics, Inc.?
Currently, no hedge funds are holding shares in ENDV
---
Company Description
Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. engages in developing off bio-electronic approach to regenerative medicine. It focuses on rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.
---
BioElectronics
―
Viveve Medical
―
Helius Medical Technologies
―
CytoDyn
―
Therapeutic Solutions International
―
Xenon
―
---